A part of Merck

688000 | Y-27632 - CAS 146986-50-7 - Calbiochem

688000
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Al finalizar el pedido Más información
Ahorró ()
 
Solicitar precio
Disponibilidad a confirmarDisponibilidad a confirmar
En existencia 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Ver precios y disponibilidad
      Click To Print This Page

      Descripción

      Replacement Information

      Tabla espec. clave

      Empirical FormulaCAS #
      C₁₄H₂₁N₃O · 2HCl · H₂O 146986-50-7

      Precios y disponibilidad

      Número de referenciaDisponiblidad Embalaje Cant./Env. Precio Cantidad
      US1688000-1MG
      Comprobando disponibilidad...
      Disponibilidad a confirmarDisponibilidad a confirmar
      En existencia 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente

          Frasco de vidrio 1 mg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          US1688000-5MG
          Comprobando disponibilidad...
          Disponibilidad a confirmarDisponibilidad a confirmar
          En existencia 
          Suspendido
          Cantidades limitadas disponibles
          Debe confirmarse disponibilidad
            El resto: se avisará
              El resto: se avisará
              Se avisará
              Póngase en contacto con el Servicio de Atención al Cliente

              Frasco de vidrio 5 mg
              Recuperando precio...
              No pudo obtenerse el precio
              La cantidad mínima tiene que ser múltiplo de
              Al finalizar el pedido Más información
              Ahorró ()
               
              Solicitar precio
              Description
              OverviewA highly potent, cell-permeable, reversible, and selective inhibitor of Rho-associated protein kinases (Ki = 140 nM for p160ROCK). Also inhibits ROCK-II with equal potency. The inhibition is competitive with respect to ATP. Exhibits 10- to 50-fold lower affinity for PKCε than p160ROCK. Does not affect the activity of p21-activated protein kinase (PAK) even at higher concentrations (~100 µM). Also acts as a potent inhibitor of agonist-induced Ca2+ sensitization of myosin phosphorylation and smooth muscle contraction. Prevents apoptosis and enhances the survival and cloning efficiency of dissociated hES cells without affecting their pluripotency. Pretreatment with Y-27632 reduces the risk of lung injury in rat models of sepsis. A 5 mM (500 µg/296 µl) solution of Y-27632 (Cat. No. 688001) in H2O and a 10 mM solution in DMSO (Cat. No. 688002) are also available.
              Catalogue Number688000
              Brand Family Calbiochem®
              SynonymsROCK Inhibitor, (R)-(+)-trans-N-(4-Pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide, 2HCl, Rho Kinase Inhibitor VI
              References
              ReferencesCinel, I., et al. 2012. J. Thorac . Dis. 4, 30.
              Watanabe, K., et al. 2007. Nature Biotech. 25, 681.
              Chitaley, K., et al. 2001. Nat. Med. 7, 119.
              Davies, S.P., et al. 2000. Biochem. J. 351, 95.
              Narumiya, S., et al. 2000. Methods Enzymol. 325, 273.
              Hirose, M., et al. 1998. J. Cell Biol. 141, 1625.
              Maekawa, M., et al. 1999. Science 285, 895.
              Uehata, M., et al. 1997. Nature 389, 990.
              Product Information
              CAS number146986-50-7
              ATP CompetitiveY
              DeclarationSold under license of PCT Application W098/06,433A1 and under license from Mitsubishi Pharma Tanabe Corporation.
              FormWhite solid
              Hill FormulaC₁₄H₂₁N₃O · 2HCl · H₂O
              Chemical formulaC₁₄H₂₁N₃O · 2HCl · H₂O
              Hygroscopic Hygroscopic
              ReversibleY
              Structure formula Image
              Applications
              ApplicationY-27632, CAS 146986-50-7, is a cell-permeable, reversible, inhibitor of Rho kinases (Ki = 140 nM for p160ROCK). Enhances survival & cloning efficiency of ESC without affecting their pluripotency.
              Biological Information
              Primary Targetp160 Rho-associated protein kinases (ROCK)
              Primary Target K<sub>i</sub>140 nM for p160 Rho-associated protein kinases (ROCK)
              Purity≥95% by HPLC
              Physicochemical Information
              Cell permeableY
              Dimensions
              Materials Information
              Toxicological Information
              Safety Information according to GHS
              Safety Information
              R PhraseR: 20/21/22

              Harmful by inhalation, in contact with skin and if swallowed.
              S PhraseS: 36

              Wear suitable protective clothing.
              Product Usage Statements
              Storage and Shipping Information
              Ship Code Ambient Temperature Only
              Toxicity Harmful
              Storage -20°C
              Protect from Light Protect from light
              Hygroscopic Hygroscopic
              Do not freeze Ok to freeze
              Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for 6 months at -20°C.
              Packaging Information
              Packaged under inert gas Packaged under inert gas
              Transport Information
              Supplemental Information
              Specifications

              Documentation

              Ficha datos de seguridad (MSDS)

              Título

              Ficha técnica de seguridad del material (MSDS) 

              Certificados de análisis

              CargoNúmero de lote
              688000

              Referencias bibliográficas

              Visión general referencias
              Cinel, I., et al. 2012. J. Thorac . Dis. 4, 30.
              Watanabe, K., et al. 2007. Nature Biotech. 25, 681.
              Chitaley, K., et al. 2001. Nat. Med. 7, 119.
              Davies, S.P., et al. 2000. Biochem. J. 351, 95.
              Narumiya, S., et al. 2000. Methods Enzymol. 325, 273.
              Hirose, M., et al. 1998. J. Cell Biol. 141, 1625.
              Maekawa, M., et al. 1999. Science 285, 895.
              Uehata, M., et al. 1997. Nature 389, 990.

              Citas

              Título
            • Cinel, I., et al. 2012. J. Thorac . Dis. 4, 30.
            • Jennifer L. Farmer, et al. (2008) Galectin 15 (LGALS15) functions in trophectoderm migration and attachment. Federation of American Societies for Experimental Biology Journal 22, 548-560.
            • James J. Fiordalisi, Patricia J. Keller and Adrienne D. Cox. (2006) PRL Tyrosine Phosphatases Regulate Rho Family GTPases to Promote Invasion and Motility. Cancer Research 66, 3153-3161.
            • Karen E. Porter, et al. (2004) Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovascular Research 61, 745-755.
            • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
            • Ficha técnica

              Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

              Revision27-February-2012 RFH
              SynonymsROCK Inhibitor, (R)-(+)-trans-N-(4-Pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide, 2HCl, Rho Kinase Inhibitor VI
              DescriptionA highly potent, cell-permeable, reversible, and selective inhibitor of Rho-associated protein kinase (Ki = 140 nM for p160ROCK (ROCK-I). Also inhibits ROCK-II with almost equal potency. Inhibition is achieved by competing with ATP for binding to the catalytic site. Exhibits 10- to 50-fold lower affinity for PKCε than p160ROCK. Does not affect the activity of p21-activated protein kinase (PAK) even at high concentrations (~100 µM). Also acts as a potent inhibitor of agonist-induced Ca2+ sensitization of myosin phosphorylation and smooth muscle contractions (IC50 = 700 nM for phenylephrine-induced contractions in aortic strips). Prevents apoptosis and enhances the survival and cloning efficiency of dissociated hES cells without affecting their pluripotency. Pretreatment with Y-27632 reduces the risk of lung injury in rat models of sepsis.
              FormWhite solid
              Intert gas (Yes/No) Packaged under inert gas
              CAS number146986-50-7
              Chemical formulaC₁₄H₂₁N₃O · 2HCl · H₂O
              Structure formula
              Purity≥95% by HPLC
              SolubilityH₂O (100 mg/ml)
              Storage -20°C
              Protect from light
              Hygroscopic
              Do Not Freeze Ok to freeze
              Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for 6 months at -20°C.
              Toxicity Harmful
              ReferencesCinel, I., et al. 2012. J. Thorac . Dis. 4, 30.
              Watanabe, K., et al. 2007. Nature Biotech. 25, 681.
              Chitaley, K., et al. 2001. Nat. Med. 7, 119.
              Davies, S.P., et al. 2000. Biochem. J. 351, 95.
              Narumiya, S., et al. 2000. Methods Enzymol. 325, 273.
              Hirose, M., et al. 1998. J. Cell Biol. 141, 1625.
              Maekawa, M., et al. 1999. Science 285, 895.
              Uehata, M., et al. 1997. Nature 389, 990.
              Citation
            • Cinel, I., et al. 2012. J. Thorac . Dis. 4, 30.
            • Jennifer L. Farmer, et al. (2008) Galectin 15 (LGALS15) functions in trophectoderm migration and attachment. Federation of American Societies for Experimental Biology Journal 22, 548-560.
            • James J. Fiordalisi, Patricia J. Keller and Adrienne D. Cox. (2006) PRL Tyrosine Phosphatases Regulate Rho Family GTPases to Promote Invasion and Motility. Cancer Research 66, 3153-3161.
            • Karen E. Porter, et al. (2004) Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovascular Research 61, 745-755.
            • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.